Sonendo receives FDA clearance for next generation of GentleWave

Sonendo announced recently that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the next generation of its GentleWave System. According to the company, this clearance provides the endodontist with the choice of using the default treatment cycles or reducing the treatment cycles as desired based on their evaluation of a tooth for root canal treatment using the GentleWave System.

Leave a Reply

Your email address will not be published. Required fields are marked *